Screener
Emergent Biosolutions EBS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Commercial Products | $52.4M-22.4% | $42.9M-5.3% | $38.4M-41.0% | $74.9M-21.4% | $67.5M-43.8% | |
| MCM Products | $168M+188% | $101.8M-35.0% | $99.2M-15.1% | $142.5M-18.2% | $58.4M-7.9% | |
| Total revenues by Product | ||||||
| All other revenue | $13.9M-7.3% | $11.4M-43.8% | $11.1M-13.3% | $13.7M-43.6% | $15M-79.0% | |
| Commercial Product sales | $52.4M-22.4% | $42.9M-5.3% | $38.4M-41.0% | $74.9M-21.4% | $67.5M-43.8% | |
| MCM Product sales | $168M+188% | $101.8M-35.0% | $99.2M-15.1% | $142.5M-18.2% | $58.4M-7.9% |
FAQ
- How does Emergent Biosolutions break its business down?
- Emergent Biosolutions (EBS) reports total revenues by business across 2 parts — Commercial Products and MCM Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Emergent Biosolutions's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Emergent Biosolutions's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
